" class="no-js "lang="en-US"> Cardio-CARE - Medtech Alert
Monday, October 07, 2024
Cardio-CARE | Pharmtech Focus

Cardio-CARE

About Cardio-CARE

Cardio-CARE

Welcome to our world that understand Customer needs a world that actually cares. Cardio care established in Year 2000 is a north India based leading a medical equipment selling company in field of Cardio, Neonatal, Pediatrics, Anaesthesia, ENT, Skin, Medicine &, Gynaecology. Our focus is on dedicating to supply excellent Medical & Hospital Equipment with most competitive Prices. Our Mission is to satisfy our clients with considerate, steadfast, and Passionate support so as to be Customer reliable partner. While outstanding quality is the company’s foundation. All Products are manufactured with ISO, CE or FDA Certificate. Excellent quality, competitive prices: such a high cost-effective, will give Customer best advantage to the market. We are a Professional staff doing every effort to provide you top-ranking Products and services. We can promise that our service is a flexible and efficient. We always help you to hold advantage of competition. We stick to delivering our high quality product and best services to our customer. We believe that we are your best choice. An even more beautiful future will begin when our hands join together. Mr. Naveen Ahuja founder of this company. He is engaged in selling medical equipments from last 18 year. He has having experience working in some leading company in the country and also experience in selling different medical equipments. Over the year Cardio Care grown and today has a dedicated team of 15 Engineers, Who are qualified to render Prompt, responsive & effective sale and service to its customer. We are represent some world leading company like Physio control ( USA), Masimo (USA), Drager (Germany), Inspiration (UK), Das ( Italy), Kub tec (USA), Sylvan Med (USA), Simtek (IND) and Phoenix (IND). We are supplying our products to various department like Health ministry of India all states, Public and Private Hospital in India (directly or Indirectly)

Related Story

Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities

July 28 2022

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the […]